Prosecution Insights
Last updated: September 27, 2026
Application No. 18/848,465

PHYTO-ANALYSIS SENSOR

Final Rejection §112
Filed
Sep 18, 2024
Priority
Mar 19, 2022 — IT 102022000005294 +1 more
Examiner
NOGUEROLA, ALEXANDER STEPHAN
Art Unit
1795
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Plantvoice Srl Sb
OA Round
2 (Final)
83%
Grant Probability
Favorable
3-4
OA Rounds
7m
Est. Remaining
86%
With Interview

Examiner Intelligence

Grants 83% — above average
83%
Career Allowance Rate
1284 granted / 1553 resolved
+17.7% vs TC avg
Minimal +3% lift
Without
With
+3.0%
Interview Lift
resolved cases with interview
Typical timeline
2y 8m
Avg Prosecution
29 currently pending
Career history
1571
Total Applications
across all art units

Statute-Specific Performance

§101
1.4%
-38.6% vs TC avg
§103
35.5%
-4.5% vs TC avg
§102
16.4%
-23.6% vs TC avg
§112
33.1%
-6.9% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1553 resolved cases

Office Action

§112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Status of the Rejections pending since the Office Action mailed April 22, 2026 All of the objections to the claims are withdrawn. Almost all of the rejections under 35 U.S.C. 112(b) are withdrawn. Two of these rejections are still maintained, though (previous items 10(a) and 10(q)). They are presented again below for Applicant’s convenience. Response to Arguments Although Applicant has made a good faith effort to overcome the objections to and rejections of the claims made in the previous Office Action, two of the rejections under 35 U.S.C. 112(b) have not been resolved. Also, new issues under 35 U.S.C 112(b) have arisen due to Applicant’s latest Amendment. Claim Objections Claim 13 is objected to because of the following informalities a) in claim 13, line 2, “conducting” should be – constructing --; and b) in claim 13, line 6, “(OECT)” should be – OECT – (parentheses removed). Appropriate correction is required. Claim Rejections - 35 USC § 112 Note that dependent claims will have the deficiencies of base and intervening claims. The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 1-11, 13, and 15 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention: a) for claims 1 and 15 Applicant is requested to clarify the scope of “Phyto-analysis” (claim 1, line 5 “in order to perform phyto-analysis of the plant; claim 15 - “. . . ., in a phyto-analysis database, . . . .”). If Applicant is being his own lexicographer, then please heed MPEP 2173.05(a). b) claim 13 now requires “wherein said OECT is deposited on said rigid support by adding an additive electrically sensitive to said solute to at least part of the (OECT), . . . . [italicizing by the Examiner]” It does seem that adding the indicated additive to a part of the OECT can actually be an act of depositing the OECT. Perhaps Applicant means -- wherein said OECT is modified on said rigid support by adding an additive electrically sensitive to said solute to at least part of the (OECT), . . . . -- or -- wherein said depositing OECT includes adding an additive electrically sensitive to said solute to at least part of the (OECT), . . . . -- c) claim 13 now requires “. . . ., said additive that is a molecularly imprinted polymer (MIP). [italicizing by the Examiner]” This phrase may be confusing as one reading it may understand that there is an antecedent in claim 13 (or claim 12) for the MIP. The Examiner suggests instead -- . . . ., said additive being a molecularly imprinted polymer (MIP)… -- or -- . . . ., wherein said additive d) claim 15 recites the limitation "said content of said solute" in lines 5-6. There is insufficient antecedent basis for this limitation in the claim. e) claim 15 recites the limitation "said solute content" in line 10. There is insufficient antecedent basis for this limitation in the claim. Allowable Subject Matter Claim 1 would be allowable if rewritten or amended to overcome the rejections under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), 2nd paragraph, set forth in this Office action. Claims 2-11, 13, and 15 would be allowable if rewritten to overcome the rejections under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), 2nd paragraph, set forth in this Office action and to include all of the limitations of the base claim and any intervening claims. Claims 12 and 14 are allowed. The following is a statement of reasons for the indication of allowable subject matter: see pages 15-25 (Allowable Subject Matter) of the previous Office Action. Final Rejection Applicant's amendment necessitated the new grounds of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to ALEXANDER STEPHAN NOGUEROLA whose telephone number is (571)272-1343. The examiner can normally be reached on Monday - Friday 9:00AM-5:30 PM EST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Luan Van can be reached on 571 272-8521. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of an application may be obtained from the Patent Application Information Retrieval (PAIR) system. Status information for published applications may be obtained from either Private PAIR or Public PAIR. Status information for unpublished applications is available through Private PAIR only. For more information about the PAIR system, see http://pair-direct.uspto.gov. Should you have questions on access to the Private PAIR system, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative or access to the automated information system, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /ALEXANDER S NOGUEROLA/ Primary Examiner, Art Unit 1795
Read full office action

Prosecution Timeline

Sep 18, 2024
Application Filed
Apr 22, 2026
Non-Final Rejection mailed — §112
Jul 22, 2026
Response Filed
Aug 13, 2026
Final Rejection mailed — §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12742748
NEUROTRANSMITTER CONCENTRATION MEASURING APPARATUS FOR PROVIDING SECOND DERIVATIVE-BASED NEUROTRANSMITTER CONCENTRATION MEASUREMENT RESULT OF FAST-SCAN CYCLIC VOLTAMMETRY DATA AND METHOD THEREOF
3y 6m to grant Granted Sep 22, 2026
Patent 12741282
ELECTROWETTING-ON-DIELECTRIC (EWOD) DEVICE
2y 4m to grant Granted Sep 22, 2026
Patent 12735442
TRANSITION METAL COMPLEX CONTAINING TETRADENTATE NITROGEN DONOR LIGAND AND ELECTROCHEMICAL BIOSENSOR COMPRISING SAME
3y 2m to grant Granted Sep 15, 2026
Patent 12730087
RAPID AIRBORNE VIRAL SENSOR AND METHODS RELATED THERETO
5y 1m to grant Granted Sep 08, 2026
Patent 12730086
MEASUREMENT DEVICE
2y 0m to grant Granted Sep 08, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
83%
Grant Probability
86%
With Interview (+3.0%)
2y 8m (~7m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 1553 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month